LD-2 disclosure · 4th Quarter - Report
MERCK
Client
- Name
- MERCK
- Description
- A research-intensive biopharmaceutical company
- Location
- New Jersey · United States of America
Registrant
- Description
- Health care policy and regulatory and legislative consulting
- Location
- Washington, District of Columbia, United States of America
Lobbying activities
4 issuesHealth Issues
H.R. 5376, the Build Back Better Act no specific bills, innovation, non-interference, 340B, Hepatitis C, HPV, Shingles, anti-microbial resistance, transparency, Pandemic All Hazards Preparedness Act reauthorization, drug pricing, anti-microbial resistance, transparency, vaccines
LobbyistsRAISSA H DOWNS · JENNIFER B YOUNG · MICHELLE P EASTON · ELIZABETH T MURRAY · CHARLOTTE SPEARS IVANCIC · PAMELA SMITH · EMILY H MURRY · KIMBERLY LYNN BRANDT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Medicare/Medicaid
H.R. 5376, the Build Back Better Act no specific bills, access to contraception, immunization access, MedPAC, icd-10, Part D, CMMI, Vaccines for Children Program, Coding, prescription drug access and affordability, value based arrangements, Medicaid, Medicare Part B, Medicare Part D, rebate cap, benefit design, patient out of pocket
LobbyistsRAISSA H DOWNS · JENNIFER B YOUNG · MICHELLE P EASTON · ELIZABETH T MURRAY · CHARLOTTE SPEARS IVANCIC · PAMELA SMITH · EMILY H MURRY · KIMBERLY LYNN BRANDT
TargetedSENATE · HOUSE OF REPRESENTATIVES · Centers For Medicare and Medicaid Services (CMS)
Budget/Appropriations
deficit reduction, appropriations, ARPA-H, reconciliation H.R. 5376, the Build Back Better Act
